ML221

ML221 is a drug which is a selective, small-molecule antagonist for the apelin receptor. It is primarily used for research into the function of this receptor pathway, but also has potential medical applications.
Wikipedia contributors, "ML221", Wikipedia, revision 1383323878, retrieved 20 November 2026, source, CC BY-SA 4.0.